...
首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >IgA anticardiolipin and IgA anti-beta 2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome
【24h】

IgA anticardiolipin and IgA anti-beta 2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome

机译:通过荧光酶免疫法测定原发性抗磷脂综合征中的IgA抗心磷脂和IgA抗β2糖蛋白I抗体阳性

获取原文
获取原文并翻译 | 示例

摘要

Background: Primary antiphospholipid syndrome (PAPS) is an autoimmune disease characterized by thrombosis and/or pregnancy morbidity as well as blood antiphospholipid (aPL) antibodies such as anticardiolipin (aCL), anti-beta 2 glycoprotein I (anti-beta 2GPI) antibodies of the IgG/IgM isotype and lupus anticoagulant (LA). The clinical significance of aCL and anti-beta 2GPI antibodies of the IgA isotype in PAPS is still a controversial issue.
机译:背景:原发性抗磷脂综合征(PAPS)是一种自身免疫性疾病,其特征在于血栓形成和/或妊娠发病率以及血液抗磷脂(aPL)抗体,例如抗心磷脂(aCL),抗β2糖蛋白I(抗β2GPI)抗体IgG / IgM同种型和狼疮抗凝剂(LA)。 PAPS中IgA同型的aCL和抗β2GPI抗体的临床意义仍然是一个有争议的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号